title: Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis.
abstract: BACKGROUND
  Hyperlipidaemia leads to glomerulosclerosis in small mammals and may contribute to progressive renal disease in man. One prominent feature of lipid-induced glomerular injury in animal models is the accumulation of mesangial matrix. These studies were designed to investigate whether low-density lipoprotein (LDL) enhanced mesangial cell (MC) matrix deposition by modulating the production of proteoglycans (PG) and hyaluronan (HA).
  
  
  METHODS
  Growth arrested human MC were metabolically labelled with either 50 microCi/ml Na(2)[(35)S]sulphate or 25 microCi/ml [(3)H]glucosamine and stimulated with LDL (10-100 microg/ml). The radiolabelled PG and HA extracted from the cell layer and the culture medium were isolated, quantified and characterized. Comparison of the PG core proteins synthesized by MC was carried out using Western blot analysis.
  
  
  RESULTS
  LDL stimulation led to a dose- and time-dependent increase in [(35)S]sulphate incorporation into PG in the culture medium and to a lesser extent in the cell layer. Analysis of the glycosaminoglycan (GAG) chains showed no difference in either their size or charge. Enzyme digestion studies demonstrated that the synthesis of both chondroitin sulphate PG (CSPG) and heparan sulphate PG (HSPG) was enhanced as was the production of the core proteins of versican (a large CSPG), perlecan (a basement membrane HSPG) and to a lesser extent decorin (a small dermatan sulphate PG (DSPG)). An increase in HA synthesis was also demonstrated in [(3)H]glucosamine labelled cells following LDL stimulation.
  
  
  CONCLUSIONS
  LDL selectively enhances the synthesis of specific PG and HA by mesangial cells. Such effects may contribute to the expansion of the mesangial matrix and modify cell-matrix interactions in lipid-induced renal damage.
authors.affiliation: University of Wales College of Medicine, Institute of Nephrology, Heath Park, Cardiff, UK.
authors.forename: R S
authors.initials: RS
authors.lastname: Chana
authors.forename: D C
authors.initials: DC
authors.lastname: Wheeler
authors.forename: G J
authors.initials: GJ
authors.lastname: Thomas
authors.forename: J D
authors.initials: JD
authors.lastname: Williams
authors.forename: M
authors.initials: M
authors.lastname: Davies
mesh_terms: D015153:Blotting, Western; D002478:Cells, Cultured; D005920:Glomerular Mesangium / Q000187:drug effects / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000096:biosynthesis; D006801:Humans; D006820:Hyaluronic Acid / Q000096:biosynthesis*; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D011509:Proteoglycans / Q000096:biosynthesis*; D013431:Sulfates / Q000378:metabolism
chemical_list: D006025:Glycosaminoglycans; D008077:Lipoproteins, LDL; D011509:Proteoglycans; D013431:Sulfates; D006820:Hyaluronic Acid